S. Oro

7.2k total citations
206 papers, 2.4k citations indexed

About

S. Oro is a scholar working on Pathology and Forensic Medicine, Dermatology and Rheumatology. According to data from OpenAlex, S. Oro has authored 206 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Pathology and Forensic Medicine, 88 papers in Dermatology and 78 papers in Rheumatology. Recurrent topics in S. Oro's work include Autoimmune Bullous Skin Diseases (78 papers), Drug-Induced Adverse Reactions (64 papers) and Urticaria and Related Conditions (63 papers). S. Oro is often cited by papers focused on Autoimmune Bullous Skin Diseases (78 papers), Drug-Induced Adverse Reactions (64 papers) and Urticaria and Related Conditions (63 papers). S. Oro collaborates with scholars based in France, United States and Switzerland. S. Oro's co-authors include O. Chosidow, P. Wolkenstein, Nicolás Ortonne, L. Valeyrie‐Allanore, T.A. Duong, Nicolas de Prost, M. Beylot‐Barry, P. Joly, Louis Dubertret and É. Sbidian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

S. Oro

178 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Oro France 27 1.4k 1.0k 812 765 511 206 2.4k
B. Crickx France 28 646 0.4× 1.0k 1.0× 895 1.1× 975 1.3× 874 1.7× 118 3.1k
David A. Wetter United States 34 707 0.5× 1.1k 1.1× 1.4k 1.8× 399 0.5× 1.2k 2.3× 116 3.5k
Charles Camisa United States 28 1.1k 0.8× 627 0.6× 757 0.9× 131 0.2× 578 1.1× 116 2.7k
Maryam Daneshpazhooh Iran 28 1.9k 1.3× 1.1k 1.1× 624 0.8× 68 0.1× 329 0.6× 221 2.9k
Sylvia Hsu United States 23 613 0.4× 460 0.4× 1.0k 1.3× 217 0.3× 326 0.6× 142 2.2k
P. Plantin France 18 605 0.4× 529 0.5× 290 0.4× 170 0.2× 173 0.3× 101 1.4k
F. Truchetet France 22 271 0.2× 385 0.4× 433 0.5× 410 0.5× 246 0.5× 86 1.6k
Yoshiko Mizukawa Japan 22 387 0.3× 743 0.7× 594 0.7× 1.0k 1.4× 235 0.5× 68 1.9k
Amaro García‐Diez Spain 26 609 0.4× 465 0.5× 1.1k 1.3× 111 0.1× 794 1.6× 171 2.7k
Yoko Kano Japan 28 616 0.4× 1.7k 1.6× 568 0.7× 2.2k 2.9× 514 1.0× 74 2.8k

Countries citing papers authored by S. Oro

Since Specialization
Citations

This map shows the geographic impact of S. Oro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Oro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Oro more than expected).

Fields of papers citing papers by S. Oro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Oro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Oro. The network helps show where S. Oro may publish in the future.

Co-authorship network of co-authors of S. Oro

This figure shows the co-authorship network connecting the top 25 collaborators of S. Oro. A scholar is included among the top collaborators of S. Oro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Oro. S. Oro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oro, S., Lars E. French, & P. Wolkenstein. (2025). Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: How to Improve the Evaluation of Therapeutic Strategies. Journal of Investigative Dermatology. 145(7). 1559–1561.
2.
Oro, S., et al.. (2025). Diagnosing and Managing Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis in Adults: Review of Evidence 2017–2023. Journal of Investigative Dermatology. 145(7). 1589–1603. 1 indexed citations
3.
Belmondo, Thibaut, et al.. (2024). Maintenance treatment of pemphigus with rituximab in real life: A single-center study of 50 patients. Annales de Dermatologie et de Vénéréologie. 151(2). 103264–103264. 1 indexed citations
4.
Botterel, Françoise, et al.. (2024). Candidaemia and Candida colonization in patients with epidermal necrolysis: a retrospective case series. British Journal of Dermatology. 191(5). 841–843. 1 indexed citations
5.
Sbidian, É., et al.. (2023). Reality of drug-induced erythema multiforme: A French pharmacovigilance study. Therapies. 78(6). 711–719. 1 indexed citations
6.
Lemonnier, François, et al.. (2023). Lymphome NK/T de type nasal à présentation cutanée inaugurale. 3(8). 790–793.
7.
Hoisnard, Léa, et al.. (2023). Validation of an Algorithm to Identify Epidermal Necrolysis on a Medico-Administrative Database. Journal of Investigative Dermatology. 144(3). 708–710.e7. 4 indexed citations
8.
Tancrède‐Bohin, Emmanuelle, M. Alexandre, S. Oro, et al.. (2023). Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national study. Journal of the American Academy of Dermatology. 90(1). 204–208. 2 indexed citations
9.
Descamps, V., François Chasset, T. Mahévas, et al.. (2022). Erythema multiforme associated with anti‐plakin antibodies: a multicentric retrospective case series. Journal of the European Academy of Dermatology and Venereology. 36(12). 2438–2442. 5 indexed citations
10.
Skayem, Charbel, L. Fardet, Khaled Ezzedine, et al.. (2021). Which patients present to dermatologic emergencies? A survey on 1561 patients. Journal of the European Academy of Dermatology and Venereology. 35(9). e583–e585.
11.
Mitamura, Yasutaka, Daniel Schulz, S. Oro, et al.. (2021). Cutaneous and systemic hyperinflammation drives maculopapular drug exanthema in severely ill COVID‐19 patients. Allergy. 77(2). 595–608. 24 indexed citations
12.
13.
Ortonne, Nicolás, Laura Pelletier, M. Beylot‐Barry, et al.. (2020). Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders. The American Journal of Surgical Pathology. 44(7). 862–872. 28 indexed citations
14.
Lefaucheur, Jean‐Pascal, L. Valeyrie‐Allanore, Sophie Ng Wing Tin, et al.. (2020). Chronic pain: a long‐term sequela of epidermal necrolysis (Stevens–Johnson syndrome/toxic epidermal necrolysis) – prevalence, clinical characteristics and risk factors. Journal of the European Academy of Dermatology and Venereology. 35(1). 188–194. 9 indexed citations
15.
Lefaucheur, Jean‐Pascal, L. Valeyrie‐Allanore, A. Colin, et al.. (2020). Involvement of small‐diameter nerve fibres in long‐term chronic pain after Stevens–Johnson syndrome or toxic epidermal necrolysis. A neurophysiological assessment. Journal of the European Academy of Dermatology and Venereology. 35(3). e218–e221. 1 indexed citations
16.
Bernard, P., Jean François Meritet, P. Wolkenstein, et al.. (2018). Pemphigus et herpès : enquête multicentrique et revue de la littérature. Annales de Dermatologie et de Vénéréologie. 145(8-9). 477–485. 1 indexed citations
17.
Gottlieb, J., S. Oro, M. Alexandre, et al.. (2016). Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults. British Journal of Dermatology. 177(1). 212–222. 34 indexed citations
18.
Foulet, F., S. Oro, Nicolás Ortonne, et al.. (2015). Cutaneous Invasive Aspergillosis. Medicine. 94(26). e1018–e1018. 51 indexed citations
19.
Oro, S.. (2011). Dermatose à IgA linéaire : revue de la littérature. Annales de Dermatologie et de Vénéréologie. 138(3). 214–220. 15 indexed citations
20.
Roux‐Villet, C. Le, et al.. (2010). Rôle infirmier dans la prise en charge de la pemphigoïde bulleuse. La Revue de l Infirmière. 38–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Crickx Breakdown of academic impact, for papers by David A. Wetter Breakdown of academic impact, for papers by Charles Camisa Breakdown of academic impact, for papers by Maryam Daneshpazhooh Breakdown of academic impact, for papers by Sylvia Hsu Breakdown of academic impact, for papers by P. Plantin Breakdown of academic impact, for papers by F. Truchetet Breakdown of academic impact, for papers by Yoshiko Mizukawa Breakdown of academic impact, for papers by Amaro García‐Diez Breakdown of academic impact, for papers by Yoko Kano
Rankless by CCL
2026